NYSE:IVC

Invacare Stock Forecast, Price & News

$7.93
-0.30 (-3.65 %)
(As of 06/18/2021 12:00 AM ET)
Add
Compare
Today's Range
$7.92
$8.18
50-Day Range
$7.73
$9.03
52-Week Range
$5.90
$10.94
Volume764,088 shs
Average Volume404,327 shs
Market Capitalization$277.19 million
P/E RatioN/A
Dividend YieldN/A
Beta0.83
30 days | 90 days | 365 days | Advanced Chart
Receive IVC News and Ratings via Email

Sign-up to receive the latest news and ratings for Invacare and its competitors with MarketBeat's FREE daily newsletter.


Invacare logo

About Invacare

Invacare Corporation, together with its subsidiaries, designs, manufactures, distributes, and exports medical equipment for use in home health care, retail, and extended care markets worldwide. The company offers mobility and seating products, such as power wheelchairs under the Invacare TDX brand; custom manual wheelchairs under the Invacare, Invacare Top End, and Küschall brand names; and seating and positioning products under the Invacare brand, as well as custom molded seat modules under the PinDot brand. It also provides lifestyle products, including pressure relieving overlays and mattress systems under the Invacare Softform and microAIR brands; safe patient handling products under the Birdie, Evo, and ISA brands; residential and institutional care beds and bed accessories, and manual wheelchairs under the Invacare brand name; and personal care products. In addition, the company offers respiratory therapy products comprising stationary oxygen concentrators under the Platinum and Perfecto2 brands; portable oxygen concentrators under the Platinum brand; and Invacare HomeFill oxygen systems. Further, it provides repair, equipment rentals, and external contracting services, as well as distributes heart rate monitors, thermometers, and nebulizers; and portable ramps. The company sells its products primarily to home medical equipment providers through retail and e-commerce channels, as well as to residential care operators, dealers, and government health service customers through its sales force, independent manufacturers' representatives, and distributors. Invacare Corporation was founded in 1885 and is headquartered in Elyria, Ohio.

Headlines

Invacare (NYSE:IVC) Issues FY 2021 Earnings Guidance
Invacare (NYSE:IVC) Issues FY 2021 Earnings Guidance
May 26, 2021 |  americanbankingnews.com
See More Headlines

Industry, Sector and Symbol

Sales & Book Value

Profitability

Debt

Price-To-Earnings

Miscellaneous

Social Links


MarketRank

Overall MarketRank

1.04 out of 5 stars

Medical Sector

1078th out of 2,100 stocks

Surgical Appliances & Supplies Industry

23rd out of 40 stocks

Analyst Opinion: 0.0Community Rank: 2.3Dividend Strength: 0.0Insider Behavior: 1.7Valuation: 1.3 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles











Invacare (NYSE:IVC) Frequently Asked Questions

Is Invacare a buy right now?

1 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Invacare in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street analysts is that investors should "buy" Invacare stock.
View analyst ratings for Invacare
or view top-rated stocks.

What stocks does MarketBeat like better than Invacare?

Wall Street analysts have given Invacare a "Buy" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Invacare wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Invacare's next earnings date?

Invacare is scheduled to release its next quarterly earnings announcement on Wednesday, August 4th 2021.
View our earnings forecast for Invacare
.

How were Invacare's earnings last quarter?

Invacare Co. (NYSE:IVC) posted its quarterly earnings results on Wednesday, May, 5th. The health services provider reported ($0.36) earnings per share for the quarter, missing the Zacks' consensus estimate of ($0.33) by $0.03. The health services provider had revenue of $196.20 million for the quarter, compared to analysts' expectations of $205 million. Invacare had a negative net margin of 5.20% and a negative trailing twelve-month return on equity of 8.57%. During the same quarter in the prior year, the company posted ($0.21) EPS.
View Invacare's earnings history
.

How has Invacare's stock price been impacted by Coronavirus (COVID-19)?

Invacare's stock was trading at $6.05 on March 11th, 2020 when Coronavirus (COVID-19) reached pandemic status according to the World Health Organization (WHO). Since then, IVC shares have increased by 31.1% and is now trading at $7.93.
View which stocks have been most impacted by COVID-19
.

What guidance has Invacare issued on next quarter's earnings?

Invacare issued an update on its FY 2021 earnings guidance on Wednesday, May, 26th. The company provided earnings per share (EPS) guidance of - for the period. The company issued revenue guidance of $882.34 million-$907.79 million, compared to the consensus revenue estimate of $915.17 million.

Who are Invacare's key executives?

Invacare's management team includes the following people:
  • Mr. Matthew E. Monaghan, Chairman, Pres & CEO (Age 53, Pay $2.15M)
  • Ms. Kathleen P. Leneghan, Sr. VP & CFO (Age 58, Pay $807.39k)
  • Mr. Anthony C. LaPlaca, Sr. VP, Gen. Counsel, Chief Admin. Officer & Sec. (Age 63, Pay $854.91k)
  • Mr. Ralf A. Ledda, Sr. VP & GM of EMEA (Age 53, Pay $686.1k)
  • Ms. Angela Goodwin, Chief Information Technology Officer (Age 57, Pay $505.15k)
  • Lois Lee CTP, Director of Treasury, Investor Relations & Corp. Comm.
  • Mr. Joost Beltman, Sr. VP & GM of North America (Age 52)

What is Matthew E. Monaghan's approval rating as Invacare's CEO?

51 employees have rated Invacare CEO Matthew E. Monaghan on Glassdoor.com. Matthew E. Monaghan has an approval rating of 37% among Invacare's employees. This puts Matthew E. Monaghan in the bottom 10% of approval ratings compared to other CEOs of publicly-traded companies.

Who are some of Invacare's key competitors?

What other stocks do shareholders of Invacare own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Invacare investors own include Pfizer (PFE), Intel (INTC), CrowdStrike (CRWD), Micron Technology (MU), OPKO Health (OPK), ONEOK (OKE), Corbus Pharmaceuticals (CRBP), Exelixis (EXEL), Five Prime Therapeutics (FPRX) and Inovio Pharmaceuticals (INO).

What is Invacare's stock symbol?

Invacare trades on the New York Stock Exchange (NYSE) under the ticker symbol "IVC."

Who are Invacare's major shareholders?

Invacare's stock is owned by a variety of retail and institutional investors. Top institutional investors include BlackRock Inc. (16.17%), Paradigm Capital Management Inc. NY (7.68%), Dimensional Fund Advisors LP (6.71%), Renaissance Technologies LLC (6.24%), Millennium Management LLC (6.02%) and Pura Vida Investments LLC (5.31%).
View institutional ownership trends for Invacare
.

Which major investors are selling Invacare stock?

IVC stock was sold by a variety of institutional investors in the last quarter, including Morgan Stanley, Renaissance Technologies LLC, Royce & Associates LP, North Run Capital LP, Northern Trust Corp, Millennium Management LLC, Goldman Sachs Group Inc., and Acadian Asset Management LLC.
View insider buying and selling activity for Invacare
or view top insider-selling stocks.

Which major investors are buying Invacare stock?

IVC stock was bought by a variety of institutional investors in the last quarter, including Paradigm Capital Management Inc. NY, Russell Investments Group Ltd., BlackRock Inc., Punch & Associates Investment Management Inc., Pura Vida Investments LLC, Nomura Holdings Inc., Boston Partners, and Geode Capital Management LLC.
View insider buying and selling activity for Invacare
or or view top insider-buying stocks.

How do I buy shares of Invacare?

Shares of IVC can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Invacare's stock price today?

One share of IVC stock can currently be purchased for approximately $7.93.

How much money does Invacare make?

Invacare has a market capitalization of $277.19 million and generates $850.69 million in revenue each year. The health services provider earns $-28,280,000.00 in net income (profit) each year or ($0.63) on an earnings per share basis.

How many employees does Invacare have?

Invacare employs 3,400 workers across the globe.

When was Invacare founded?

Invacare was founded in 1885.

What is Invacare's official website?

The official website for Invacare is www.invacare.com.

Where are Invacare's headquarters?

Invacare is headquartered at ONE INVACARE WAY, ELYRIA OH, 44036.

How can I contact Invacare?

Invacare's mailing address is ONE INVACARE WAY, ELYRIA OH, 44036. The health services provider can be reached via phone at (440) 329-6000 or via email at [email protected]


This page was last updated on 6/19/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research. As a bonus to opt-ing into our email newsletters, you will also get a free subscription to the Liberty Through Wealth e-newsletter. You can opt out at any time.